drugset / Trial / NCT06433661

A Research Study of the Effect of Food on Etavopivat in Healthy Participants

NCT06433661

Phase 1 Completed 16 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of food on the amount of etavopivat in the bloodstream of healthy participants. Participants will take a single oral dose of etavopivat following a high-fat meal (i.e. fed) and on an empty stomach (i.e fasted) on two separate occasions.The study will last up to 50 days (including screening).

Timeline

Start
2024-05-28
Primary completion
2024-07-06
Completion
2024-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Etavopivat Small molecule Oral